Sort
51,593 grants matching “hepatitis”
Development of a Urine Test for the Early Detection of Liver Cancer
$609,604Surbhi Jain · Jbs Science, Inc. · R44 · FY2015 · CA
Development of a Urine Test for the Early Detection of Liver Cancer
$609,604Surbhi Jain · Jbs Science, Inc. · R44 · FY2014 · CA
Biochemistry of Protein Prenylation
$609,576Michael H Gelb · University Of Washington · R01 · FY2009 · AI
Women's Risk Networks: Resources, Infection and Change
$609,561Columbia University Health Sciences · R01 · FY2001 · DA
Multiplex Next Generation Sequencing of Glycans and Nucleic Acids for Accelerating the Development of Cell Factories and Bioprocesses for Glycoprotein Biomanufacturing
$609,503Nathan E Lewis · University Of California-San Diego · · FY2024 · ENG
Core--Special Animal
$609,495Sanjeev Gupta · Albert Einstein College Of Medicine · P30 · FY2007 · DK
A Human-Centered Pharmacogenomic Screen of Metformin Action
$609,483Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2016 · DK
Administrative Core
$609,481Craig J McClain · University Of Louisville · P20 · FY2023 · GM
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk in Rural Appalachia through Harm Reduction Kiosks
$609,439April Marie Young · University Of Kentucky · R01 · FY2022 · DA
Clonal Dynamics of the antibody response
$609,409Gabriel D Victora · Rockefeller University · R01 · FY2025 · AI
Copper Homeostasis and Liver Function
$609,278Svetlana Lutsenko · Johns Hopkins University · R01 · FY2025 · DK
Oral digoxin for the treatment of NASH
$609,266Bubu Ama Banini · Yale University · R01 · FY2024 · DK
Persistent hepatitis C virus replication and immunity in pregnancy
$609,225Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · AI
Optimizing Lung Cancer Treatment in HIV Infected Persons
$609,180Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Ferroportin Structure and function
$609,107Elizabeta Nemeth · University Of California Los Angeles · R01 · FY2016 · DK
ESOPHAGEAL VARICES BY B-ADRENERGIC BLOCKERS
$609,034Yale University · R01 · FY2001 · DK
Administrative Core
$608,996Craig J McClain · University Of Louisville · P20 · FY2022 · GM
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
$608,976National Development &Res Institutes · R01 · FY2003 · DA
Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease
$608,895Yanqiao Zhang · Northeast Ohio Medical University · R01 · FY2023 · DK
Development of a 3D multi-modal perfusion-thermal electrode system
$608,893Xiaoming Yang · University Of Washington · R01 · FY2022 · EB
Developmental Regulation of Drug Processing Genes
$608,814Curtis Dean Klaassen · University Of Kansas Medical Center · R01 · FY2011 · ES
Hepatic stellate cells in liver homeostasis and regeneration
$608,691Youngmin Anna Lee · Vanderbilt University Medical Center · R01 · FY2024 · DK
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$608,641Alvin Carter Powers · Vanderbilt University Medical Center · R24 · FY2015 · DK
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B
$608,628Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Core 1: Administrative Core
$608,589Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2020 · DA